CRISPR Therapeutics AG (CRSP) — Total Assets

Annual figures by fiscal year, from SEC filings.

2015: $159.42M2016: $344.96M2017: $271.35M2018: $489.02M2019: $1.07B2020: $1.83B2021: $2.75B2022: $2.24B2023: $2.23B2024: $2.24B2025: $2.27B$2.27B
2015Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$2.27B+1.0%
2024$2.24B+0.6%
2023$2.23B-0.6%
2022$2.24B-18.5%
2021$2.75B+50.5%
2020$1.83B+71.4%
2019$1.07B+118.1%
2018$489.02M+80.2%
2017$271.35M-21.3%
2016$344.96M+116.4%
2015$159.42M